Office of the Director, National Institutes of Health; Notice of Meeting, 55850-55851 [2012-22278]

Download as PDF srobinson on DSK4SPTVN1PROD with NOTICES 55850 Federal Register / Vol. 77, No. 176 / Tuesday, September 11, 2012 / Notices Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814. Contact Person: Majed M. Hamawy, Ph.D., Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 8135, Bethesda, MD 20892, 301–594–5659, mh101v@nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; a Data Resource for Analyzing Blood and Marrow Transplants. Date: October 10, 2012. Time: 11:30 a.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6116 Executive Boulevard, Room 406, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Viatcheslav A Soldatenkov, MD, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities National Cancer Institute, 6116 Executive Blvd. Room 8057, Bethesda, MD 20892–8329, 301–451– 4758, soldatenkovv@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Small Grants Program for Cancer Epidemiology (R03). Date: October 16–17, 2012. Time: 4 p.m. to 5 p.m. Agenda: Place: To review and evaluate grant applications. Place: Embassy Suites Alexandria, 1900 Diagonal Road, Alexandria, VA 22314. Contact Person: Marvin L. Salin, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 7073, Bethesda, MD 20892–8329, 301–496–0694, msalin@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Strategic Partnering to Evaluate Cancer Signatures (SPECS II). Date: October 24–25, 2012. Time: 10 a.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6116 Executive Boulevard, Room 507, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Marvin L. Salin, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 7073, Bethesda, MD 20892–8329, 301–496–0694 msalin@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Developmental Therapeutics/Omnibus. Date: October 25–26, 2012. Time: 8:30 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: The Holiday Inn Express, 1775 Rockville Pike, Rockville, MD 20852. Contact Person: Joyce C. Pegues, Ph.D., Scientific Review Officer, Special Review VerDate Mar<15>2010 19:10 Sep 10, 2012 Jkt 226001 and Logistics Branch, Division of Extramural Activities, NIH National Cancer Institute, 6116 Executive Boulevard, Room 7149, Bethesda, MD 20892–8329, 301–594–1286, peguesj@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Cancer Detection. Date: October 29–30, 2012. Time: 4 p.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Bethesda, MD 20852. Contact Person: Viatcheslav A Soldatenkov, MD, Ph.D., Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Blvd. Room 8057, Bethesda, MD 20892–8329, 301–451– 4758, soldatenkovv@mail.nih.gov. Information is also available on the Institute’s/Center’s home page: https:// deainfo.nci.nih.gov/advisory/sep/sep.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: September 5, 2012 . Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2012–22287 Filed 9–10–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, National Institutes of Health; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a stakeholder forum hosted by the NIH Scientific Management Review Board (SMRB). In Fall 2011, the SMRB was asked by NIH to recommend strategies for how NIH can optimize its utilization of its Small Business Innovation Research/Small Business Technology Transfer (SBIR/ STTR) programs in keeping with the NIH mission. This meeting will be part of a series of sessions aimed at soliciting input from experts and stakeholders of the SBIR/STTR programs at NIH. The NIH Reform Act of 2006 (Pub. L. 109–482) provides organizational PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 authorities to HHS and NIH officials to: (1) Establish or abolish national research institutes; (2) reorganize the offices within the Office of the Director, NIH including adding, removing, or transferring the functions of such offices or establishing or terminating such offices; and (3) reorganize, divisions, centers, or other administrative units within an NIH national research institute or national center including adding, removing, or transferring the functions of such units, or establishing or terminating such units. The purpose of the Scientific Management Review Board (also referred to as SMRB or Board) is to advise appropriate HHS and NIH officials on the use of these organizational authorities and identify the reasons underlying the recommendations. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: Scientific Management Review Board Date: October 3, 2012. Time: 08:30 a.m. to 5 p.m. Agenda: Presentation and discussion will focus on the deliberations of the BIR/STTR Working Group and soliciting input during this stakeholder consultation. Presentation and discussion will include, but is not limited to, representatives from the small business community and investors in biomedical research with interest in the SBIR/STTR programs. Time will be allotted on the agenda for public comment. Sign up for public comments will begin approximately at 8 a.m. on October 3, 2012 and will be restricted to one sign-in per person. In the event that time does not allow for all those interested to present oral comments, any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Members of the public viewing the meeting via webcast (see https:// smrb.od.nih.gov) can submit comments during the public comment periods by submitting comments to smrb@mail.nih.gov. Only comments submitted to this address will be read. It is not unusual for the meeting to run ahead or behind schedule due to changes in the time needed for discussion. It is advisable to monitor the webcast to determine when public comments will be read. Each public comment period follows a specific discussion item. Comments related to the discussion will be read at that time. General comments unrelated to a specific agenda item will be read at the end of the meeting, time permitting. Comments submitted by email through E:\FR\FM\11SEN1.SGM 11SEN1 Federal Register / Vol. 77, No. 176 / Tuesday, September 11, 2012 / Notices smrb@mail.nih.gov will follow comments by individuals attending the meeting. Comments will be read in the order received and your name and affiliation will be read with the comments. Please note, time may not permit for every comment received to be read in the time allotted for public comment. Comments not read will become part of the public record. Place: National Institutes of Health, Building 31, C-Wing, 6th Floor, Conference Room 10, 31 Center Drive, Bethesda, MD 20892. Contact Person: Lyric Jorgenson, Ph.D., Office of Science Policy, Office of the Director, NIH, National Institutes of Health, 6705 Rockledge Drive, Suite 750, Bethesda, MD 20892, smrb@mail.nih.gov, (301) 496– 6837. The meeting will also be webcast. The draft meeting agenda and other information about the SMRB, including information about access to the webcast, will be available at https://smrb.od.nih.gov. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxis, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. (Catalogue of Federal Domestic Assistance Program Nos. 93.14, Intramural Research Training Award; 93.22, Clinical Research Loan Repayment Program for Individuals from Disadvantaged Backgrounds; 93.232, Loan Repayment Program for Research Generally; 93.39, Academic Research Enhancement Award; 93.936, NIH Acquired Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, Undergraduate Scholarship Program for Individuals from Disadvantaged Backgrounds, National Institutes of Health, HHS) Dated: September 5, 2012. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2012–22278 Filed 9–10–12; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health srobinson on DSK4SPTVN1PROD with NOTICES Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose VerDate Mar<15>2010 19:10 Sep 10, 2012 Jkt 226001 confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Neurobiology of Brain Disease. Date: October 3, 2012. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Boris P Sokolov, Ph.D.,, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5217A, MSC 7846, Bethesda, MD 20892, 301–408– 9115, bsokolov@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Retinopathy and Diabetic Eyes. Date: October 3, 2012. Time: 12 p.m. to 2 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: James P Harwood, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5168, MSC 7840, Bethesda, MD 20892, 301–435– 1256, harwoodj@csr.nih.gov. Name of Committee: Endocrinology, Metabolism, Nutrition and Reproductive Sciences, Integrated Review Group; Integrative Nutrition and Metabolic Processes Study Section. Date: October 4, 2012. Time: 7:30 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton Delfina Santa Monica Hotel, 530 West Pico Boulevard, Santa Monica, CA 90405. Contact Person: Dianne Camp, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6164, Bethesda, MD 20892, 301–435–1044, campdm@mail.nih.gov. Name of Committee: Musculoskeletal, Oral and Skin Sciences Integrated Review Group; Oral, Dental and Craniofacial Sciences Study Section. Date: October 10–11, 2012. Time: 8 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW, Washington, DC 20015. Contact Person: Yi-Hsin Liu, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4214, MSC 7814, Bethesda, MD 20892, 301–435– 1781, liuyh@csr.nih.gov. PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 55851 Name of Committee: Cell Biology Integrated Review Group; Development—1 Study Section. Date: October 10, 2012. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Fisherman’s Wharf, 2620 Jones Street, San Francisco, CA 94133. Contact Person: Jonathan Arias, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5170, MSC 7840, Bethesda, MD 20892, 301–435– 2406, ariasj@csr.nih.gov. Name of Committee: Digestive, Kidney and Urological Systems Integrated Review Group; Xenobiotic and Nutrient Disposition and Action Study Section. Date: October 10, 2012. Time: 8 a.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Patricia Greenwel, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2172, MSC 7818, Bethesda, MD 20892, 301–435– 1169, greenwep@csr.nih.gov. Name of Committee: Oncology 1-Basic Translational Integrated Review Group; Tumor Cell Biology Study Section. Date: October 10–11, 2012. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hotel Kabuki, 1625 Post Street, San Francisco, CA 94115. Contact Person: Charles Morrow, Ph.D., M.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6202, MSC 7804, Bethesda, MD 20892, 301–451– 4467, morrowcs@csr.nih.gov. Name of Committee: Interdisciplinary Molecular Sciences and Training Integrated Review Group; Enabling Bioanalytical and Imaging Technologies Study Section. Date: October 10–11, 2012. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton Gunter Hotel, 205 E. Houston Street, San Antonio, TX 78205. Contact Person: Vonda K Smith, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4148, MSC 7801, Bethesda, MD 20892, 301–435– 1789, smithvo@csr.nih.gov. Name of Committee: Bioengineering Sciences & Technologies Integrated Review Group; Instrumentation and Systems Development Study Section. Date: October 10–11, 2012. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton Suites Old Town Alexandria, 801 North Saint Asaph Street, Alexandria, VA 22314. Contact Person: Kathryn Kalasinsky, Ph.D., Scientific Review Officer, Center for E:\FR\FM\11SEN1.SGM 11SEN1

Agencies

[Federal Register Volume 77, Number 176 (Tuesday, September 11, 2012)]
[Notices]
[Pages 55850-55851]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-22278]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a stakeholder forum 
hosted by the NIH Scientific Management Review Board (SMRB). In Fall 
2011, the SMRB was asked by NIH to recommend strategies for how NIH can 
optimize its utilization of its Small Business Innovation Research/
Small Business Technology Transfer (SBIR/STTR) programs in keeping with 
the NIH mission. This meeting will be part of a series of sessions 
aimed at soliciting input from experts and stakeholders of the SBIR/
STTR programs at NIH.
    The NIH Reform Act of 2006 (Pub. L. 109-482) provides 
organizational authorities to HHS and NIH officials to: (1) Establish 
or abolish national research institutes; (2) reorganize the offices 
within the Office of the Director, NIH including adding, removing, or 
transferring the functions of such offices or establishing or 
terminating such offices; and (3) reorganize, divisions, centers, or 
other administrative units within an NIH national research institute or 
national center including adding, removing, or transferring the 
functions of such units, or establishing or terminating such units. The 
purpose of the Scientific Management Review Board (also referred to as 
SMRB or Board) is to advise appropriate HHS and NIH officials on the 
use of these organizational authorities and identify the reasons 
underlying the recommendations.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: Scientific Management Review Board
    Date: October 3, 2012.
    Time: 08:30 a.m. to 5 p.m.
    Agenda: Presentation and discussion will focus on the 
deliberations of the BIR/STTR Working Group and soliciting input 
during this stakeholder consultation. Presentation and discussion 
will include, but is not limited to, representatives from the small 
business community and investors in biomedical research with 
interest in the SBIR/STTR programs. Time will be allotted on the 
agenda for public comment. Sign up for public comments will begin 
approximately at 8 a.m. on October 3, 2012 and will be restricted to 
one sign-in per person. In the event that time does not allow for 
all those interested to present oral comments, any interested person 
may file written comments with the committee by forwarding the 
statement to the Contact Person listed on this notice. The statement 
should include the name, address, telephone number and when 
applicable, the business or professional affiliation of the 
interested person. Members of the public viewing the meeting via 
webcast (see https://smrb.od.nih.gov) can submit comments during the 
public comment periods by submitting comments to smrb@mail.nih.gov. 
Only comments submitted to this address will be read. It is not 
unusual for the meeting to run ahead or behind schedule due to 
changes in the time needed for discussion. It is advisable to 
monitor the webcast to determine when public comments will be read. 
Each public comment period follows a specific discussion item. 
Comments related to the discussion will be read at that time. 
General comments unrelated to a specific agenda item will be read at 
the end of the meeting, time permitting. Comments submitted by email 
through

[[Page 55851]]

smrb@mail.nih.gov will follow comments by individuals attending the 
meeting. Comments will be read in the order received and your name 
and affiliation will be read with the comments. Please note, time 
may not permit for every comment received to be read in the time 
allotted for public comment. Comments not read will become part of 
the public record.
    Place: National Institutes of Health, Building 31, C-Wing, 6th 
Floor, Conference Room 10, 31 Center Drive, Bethesda, MD 20892.
    Contact Person: Lyric Jorgenson, Ph.D., Office of Science 
Policy, Office of the Director, NIH, National Institutes of Health, 
6705 Rockledge Drive, Suite 750, Bethesda, MD 20892, 
smrb@mail.nih.gov, (301) 496-6837.

    The meeting will also be webcast. The draft meeting agenda and 
other information about the SMRB, including information about access 
to the webcast, will be available at https://smrb.od.nih.gov.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxis, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)

    Dated: September 5, 2012.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-22278 Filed 9-10-12; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.